Patient Buzz: Menopausal Skin | The Expert Weighs In
menopausal skinMenopausal skin was the subject of a recent FOX News interview with Amy Weschler, MD, PhD, who is board certified in dermatology and psychiatry. In the interview, Dr. Weschler addressed acne during menopause as well as the impact of stress and sleep on the skin. She included recommendations for stress management that can lead to skin improvements. For a deeper dive into the skin effects of meno …
menopausal skin
Hedgehog Pathway Inhibitors for Advanced Basal Cell Carcinoma: Optimizing Use in Clinical Practice
Hedgehog Pathway Inhibitors (HHIs)The 2026 ODAC Conference featured an expert panel discussion on evolving strategies for the use of hedgehog pathway inhibitors (HHIs), with a focus on practical clinical decision-making for dermatologists. Dr. Vishal Patel and Dr. C. William Hanke reviewed how HHIs have expanded treatment options for patients with locally advanced and metastatic basal cell carcinoma (BCC). Background and Rational …
Hedgehog Pathway Inhibitors (HHIs)
Nonscarring Alopecias: Clues & Treatment Options
nonscarring alopeciasDr. Victoria Barbosa, associate professor of medicine at the University of Chicago Pritzker School of Medicine, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about the two categories of nonscarring alopecias. Hear why Dr. Barbosa says clinicians need to give ample time to counseling patients about behavioral changes to prevent progression of hair loss. Learn about recen …
nonscarring alopecias
From the SOCU Poster Hall | Ancestry-Linked Gene Expression in Skin Disease
genes and skin diseaseSkin of color dermatology is a growing field that is gaining more attention as the U.S. population diversifies. While there’s an understanding that some skin conditions are more prevalent in certain racial and ethnic groups, there’s little understanding as to why. In addition, self-reported race and ethnicity is not a fail-safe way of understanding a person’s skin. People are often multiraci …
genes and skin disease
JDD Buzz Series | Cutaneous Adverse Events of GLP-1 Agonists
Cutaneous Adverse Events of GLP-1 agonistsGLP-1 receptor agonists are an increasingly popular treatment for type 2 diabetes and obesity. Additionally, some dermatologists are finding success with treating psoriasis and hidradenitis suppurativa with GLP-1s independent of an impact on weight loss. As GLP-1 use becomes even more common in medicine, it’s important to understand side effects, including skin effects that could lead GLP-1 pati …
Cutaneous Adverse Events of GLP-1 agonists